Cristina Izquierdo-Pascual

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary Care

SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary Care

Journal: Semergen

Published: March 10, 2026

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Journal: Journal of clinical medicine

Published: January 24, 2026

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Journal: British journal of haematology

Published: January 23, 2026

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial.

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial.

Journal: American journal of hematology

Published: October 27, 2025

EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura.

EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura.

Journal: Frontiers in immunology

Published: September 07, 2025

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Journal: British journal of haematology

Published: June 18, 2025

Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia.

Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: March 10, 2025

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry.

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry.

Journal: HemaSphere

Published: November 10, 2024

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Journal: EClinicalMedicine

Published: October 21, 2024

Bleeding Risk of Anticoagulation Reversal Strategies Before Heart Transplantation: A Retrospective Comparative Cohort Study.

Bleeding Risk of Anticoagulation Reversal Strategies Before Heart Transplantation: A Retrospective Comparative Cohort Study.

Journal: Journal of cardiovascular development and disease

Published: September 08, 2024

Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study).

Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study).

Journal: British journal of haematology

Published: August 14, 2024

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).

Journal: American journal of hematology

Published: August 13, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026